HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oncostatin M

A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.
Networked: 638 relevant articles (7 outcomes, 54 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Richards, Carl D: 19 articles (01/2020 - 05/2002)
2. Jorcyk, Cheryl L: 9 articles (10/2021 - 01/2004)
3. Blanchard, Frédéric: 8 articles (01/2016 - 12/2003)
4. Lecron, Jean-Claude: 6 articles (06/2022 - 04/2007)
5. Stephens, Jacqueline M: 6 articles (03/2020 - 02/2014)
6. Tawara, Ken: 6 articles (03/2019 - 02/2012)
7. Morel, Franck: 6 articles (01/2019 - 04/2007)
8. Tanaka, Minoru: 6 articles (01/2018 - 08/2008)
9. Rowan, A D: 6 articles (04/2014 - 07/2001)
10. Favot, Laure: 5 articles (06/2022 - 03/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
4. Myocardial Infarction
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. Cytokines
2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
3. Myokines
4. Osteopontin
5. Lipocalin-2
6. Nicotinamide Phosphoribosyltransferase
7. Adipokines
8. Resistin
9. Adiponectin
10. Leptin

Related Therapies and Procedures

1. Therapeutics
2. Root Planing
3. Heterologous Transplantation (Xenotransplantation)
4. Chemoradiotherapy
5. Lipectomy (Liposuction)